Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX®) in pediatric and nonpediatric patients with bacterial conjunctivitis: The potency, ocular penetration, and safety of moxifloxacin (as VIGAMOX® solution), a topical ophthalmic fourth-generation fluoroquinolone

Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX®) in pediatric and nonpediatric patients with bacterial conjunctivitis The potency, ocular penetration, and safety of moxifloxacin (as VIGAMOX® solution), a topical ophthalmic fourth-generation fluoroquinolone

Saved in:
Bibliographic Details
Published in:Survey of ophthalmology Vol. 50; pp. S55 - S63
Main Authors: SILVER, Lewis H, WOODSIDE, Adrienne M, MONTGOMERY, Dawnelle B
Format: Journal Article
Language:English
Published: New York, NY Elsevier Science 2005
Subjects:
Biological and medical sciences
Medical sciences
Miscellaneous
Ophthalmology
Human
Pediatrics
Toxicity
fluoroquinolone
Infant
Conjunctiva disease
Conjunctivitis
adverse events
pediatric
Infection
Eye disease
Fluoroquinolone derivatives
Ophthalmic preparation
ophthalmic
Bacteriosis
Bacteria
Complication
VIGAMOX
Ophthalmology
Safety
Child
moxifloxacin
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0039-6257
1879-3304